The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COMM | 00461U105 | 5,494,430 | 529,839 | SH | SOLE | 529,839 | 0 | 0 | |||
AEROVATE THERAPEUTICS INC | COMM | 008064107 | 37,751,849 | 2,201,274 | SH | SOLE | 2,201,274 | 0 | 0 | |||
ALPINE IMMUNE SCIENCES INC | COMM | 02083G100 | 2,601,549 | 253,069 | SH | SOLE | 253,069 | 0 | 0 | |||
AN2 Therapeutics, Inc. | COMM | 037326105 | 10,959,220 | 1,289,320 | SH | SOLE | 1,289,320 | 0 | 0 | |||
C4 THERAPEUTICS, INC. | COMM | 12529R107 | 3,510,579 | 1,276,574 | SH | SOLE | 1,276,574 | 0 | 0 | |||
CABALETTA BIO, INC | COMM | 12674W109 | 6,284,523 | 486,795 | SH | SOLE | 486,795 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COMM | 19240Q201 | 66,671,537 | 5,631,042 | SH | SOLE | 5,631,042 | 0 | 0 | |||
DYNE THERAPEUTICS, INC | COMM | 26818M108 | 18,564,188 | 1,650,150 | SH | SOLE | 1,650,150 | 0 | 0 | |||
ENTRADA THERAPEUTICS INC | COMM | 29384C108 | 8,856,219 | 584,955 | SH | SOLE | 584,955 | 0 | 0 | |||
GERON CORP | COMM | 374163103 | 75,723,191 | 23,589,779 | SH | SOLE | 23,589,779 | 0 | 0 | |||
ICOSAVAC, INC | COMM | 45114M109 | 36,777,781 | 3,703,704 | SH | SOLE | 3,703,704 | 0 | 0 | |||
IMMUNOVANT, INC | COMM | 45258J102 | 12,422,561 | 654,853 | SH | SOLE | 654,853 | 0 | 0 | |||
IVERIC BIO INC | COMM | 46583P102 | 96,336,933 | 2,448,829 | SH | SOLE | 2,448,829 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS, INC | COMM | 483497103 | 30,559,455 | 3,395,495 | SH | SOLE | 3,395,495 | 0 | 0 | |||
KURA ONCOLOGY INC | COMM | 50127T109 | 15,062,132 | 1,423,642 | SH | SOLE | 1,423,642 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COMM | 558868105 | 34,630,827 | 149,917 | SH | SOLE | 149,917 | 0 | 0 | |||
MERUS BV | COMM | N5749R100 | 7,899,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
SILENCE THERAPEUTICS PLC | ADRS | 82686Q101 | 11,576,813 | 2,104,875 | SH | SOLE | 2,104,875 | 0 | 0 | |||
TYRA BIOSCIENCES INC | COMM | 90240B106 | 33,874,424 | 1,989,103 | SH | SOLE | 1,989,103 | 0 | 0 | |||
VECTIVBIO HOLDING AG | COMM | H9060V101 | 52,931,200 | 3,113,600 | SH | SOLE | 3,113,600 | 0 | 0 | |||
VENTYX BIOSCIENCES, INC | COMM | 92332V107 | 26,755,747 | 815,724 | SH | SOLE | 815,724 | 0 | 0 | |||
STRUCTURE THERAPEUTICS INC | ADRS | 86366E106 | 14,549,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 |